This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

The Run-Up Trade: Biodel's Insulin Trial Results

Biodel shares should move higher ahead of insulin trial results in the third quarter.

Rockwell Medical Run-Up Trade Follows Financing

One trader believes Rockwell shares will rise into clinical trial results expected in July.

Synta Is Run-Up to ASCO Lung Cancer Data

The market overreacted to the resignation of Synta's R&D chief.

Expecting Ziopharm Shares To Run Into Phase III Data At Month's End

Ziopharm is an example of a stock with clinical trial results that can be traded realtively safely.

Run-Up Trade Into Dynavax's FDA Approval Decision

Three factors that will cause Dynavax shares to gain as get closer to the approval of its Hep B vaccine.

Titan Pharma: Run-Up Trade Into March FDA Panel

I expect traders will get an opportunity to profit from increased focus on Titan through March.

A.P. Pharma Run-Up Trade Into FDA Approval Decision

Look at A.P. Pharma as a trade, not as a long-term investment, says trader Mark Messier.

Shorting Alexza Pharma On FDA's Adasuve Approval

Alexza is setting up as a classic biotech run-down stock, says trader Mark Messier.

Anacor Pharma: Run-Up Trade Into January Trial Data

Anacor will be releasing phase III results for a toenail fungus drug in January.

Hyperion Shares Poised to Run Up Ahead of FDA Decision

FDA expected to issue approval decision on orphan drug Ravicti on Jan. 23.

Page 1 of 2
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs